Zdrowie i gospodarka · 31/12/2015

FDA Announces Draft Guidance for Emerging Postmarket Medical Device Signals

The US Food and Drug Administration (FDA) is releasing a draft guidance document outlining its policy for publicly notifying the public about emerging signals in postmarket medical devices, which may not have been fully analyzed or validated yet.